Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Kazanorgsintez reported for 6 months of 2023 by RAS

8/24/23 KZOS

TGC-14 reported for 6 months of 2023 by IFRS

8/24/23 TGKN

Sollers launched a full cycle of production of the Atlant van

8/24/23 SVAV

KMZ reported for 6 months of 2023 by IFRS

8/24/23 KMEZ

NetEase reported for 6 months of 2023

8/24/23 NTES

Yandex entered the market of fintech services with a product for savings

8/24/23 YNDX

Sollers transferred the production of light trucks Argo to a new site

8/24/23 SVAV

Beluga Group shareholders supported the decision to change its name to Novabev Group

8/24/23 BELU

Gazprom Neft reported for 6 months of 2023 by IFRS

8/24/23 SIBN

Nornickel opened an office in Dubai

8/24/23 GMKN